{"id":"W2047044229","doi":"10.1007/s10549-005-6941-5","title":"Celecoxib Inhibits Urokinase-Type Plasminogen Activator (uPA) Production in MDA-MB-231 Breast Cancer Cells","year":2005,"lang":"en","type":"article","venue":"Breast Cancer Research and Treatment","topic":"Inflammatory mediators and NSAID effects","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"ca_institutions":"Children's & Women's Health Centre of British Columbia","funders":"National Cancer Institute; Pfizer Canada; University of British Columbia; Pfizer","keywords":"Plasminogen activator; Urokinase; Celecoxib; Breast cancer; Cancer research; Metastatic breast cancer; Medicine; Internal medicine; Activator (genetics); Oncology; Endocrinology; Cancer; Receptor","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002160749,0.0004250371,0.000718488,0.0005393611,0.0004383315,0.0006125108,0.0002379947,0.0002952638,0.002603902],"category_scores_gemma":[0.0002325617,0.0002904169,0.0005042088,0.0006696861,0.0002210007,0.0002718704,0.0002294242,0.0009438567,0.0009717789],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005737019,"about_ca_system_score_gemma":0.0006142,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005725559,"about_ca_topic_score_gemma":0.005796844,"domain_scores_codex":[0.9995951,0.00004800506,0.00003953865,0.00002172125,0.0001284852,0.0001671295],"domain_scores_gemma":[0.9998913,0.00003159377,0.00001377104,0.00001605504,0.00002215014,0.0000250903],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001333567,0.0003410058,0.0005746119,0.0002157684,0.00003245082,0.0002862144,0.00009552165,0.0001356465,0.9883593,0.0001964225,0.001309945,0.007119505],"study_design_scores_gemma":[0.0001381421,0.0008607846,0.01000141,0.00001641693,0.00005753123,0.0005194523,0.0001543866,0.001210439,0.9774287,0.00007065073,0.009529294,0.00001261725],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9779559,0.01219858,0.001355221,0.001072181,0.0004365887,0.00005887501,0.00222848,0.0001950239,0.004499281],"genre_scores_gemma":[0.9686567,0.01155479,0.00146676,0.0002462935,0.0001306656,0.0001015327,0.005067912,0.0000235877,0.01275166],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005725559,"threshold_uncertainty_score":0.01138449,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03470165394724399,"score_gpt":0.3392442076448864,"score_spread":0.3045425536976424,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}